Aveanna Healthcare Earnings Call Signals Broader Growth, Higher Guidance
Aveanna Healthcare (AVAH) reported Q3 revenue of $695.5M, up 11.8%, and adjusted EBITDA of $100.1M, up 25%. All segments grew, with Home Health and Hospice up 15.6%, Private Duty Services up 11.6%, and Medical Solutions up 9.1%. The company raised 2026 guidance to revenue above $2.695B and adjusted EBITDA above $374M, citing growth in preferred payers and state rate enhancements. Management highlighted caregiver shortages and California rate uncertainty as risks.
How this was made
The 30-second read
Why it matters
The guidance raise is a fresh earnings disclosure that can shift investor expectations and drive short‑term price movement.
Market read
First report of higher 2026 guidance; material for traders targeting healthcare mid‑caps.
What to watch
Potential volatility from California rate uncertainty and the temporary nature of PDN funding may dampen long‑term upside.
Background
Aveanna Healthcare Holdings (AVAH) operates Home Health, Hospice, Private Duty Services, and Medical Solutions, reporting Q3 results and raising 2026 guidance.
Ticker impact
Aveanna Healthcare raised its full-year 2026 revenue guidance above $2.695 B and adjusted EBITDA above $374 M, the first disclosure of these numbers.
upward pressure as the market prices in higher full-year guidance, with limited upside due to modest Q4 outlook
Guidance lifts are material earnings news; investors typically bid the stock higher on improved revenue/EBITDA forecasts.
Market effects
Positive for the home‑health and hospice sector as Aveanna's growth signals demand strength.
U.S. healthcare services stocks may see modest gains following the guidance lift.
Limited; primarily affects U.S. mid‑cap healthcare investors.
Counterpoint
Flat Q4 outlook and ongoing caregiver labor shortages could weigh on the stock despite the guidance boost.
Key entities
- companyAveanna Healthcare Holdings Inc
U.S. home‑health and hospice provider that issued the earnings call.

